Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M578Revenue (TTM) $M570Net Margin (%)-12.3Altman Z-Score1.0
Enterprise Value $M1,167EPS (TTM) $-1.8Operating Margin %-3.3Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-10.5Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %--Current Ratio2.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-32.3ROA % (ttm)-7.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-23.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M42.9ROIC % (ttm)-0.1Gross Margin Increase y-yN

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AMRI is held by these investors:



AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MADDALUNA ANTHONY JDirector 2016-12-02Buy1,518$16.46-19.14view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-11-30Sell9,000$16.71-20.35view
HENDERSON LORI M.SVP, Secretary & Gen Counsel 2016-11-16Sell6,000$17-21.71view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-11-10Sell785$16.79-20.73view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-08-09Sell1,401$15.29-12.95view
OCONNOR KEVINDirector 2016-05-31Sell5,000$14.41-7.63view
Marth William SPresident and CEO 2016-05-16Buy12,500$12.863.5view
Svokos GeorgeCOO 2016-05-13Buy12,500$12.823.82view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-05-13Sell2,361$12.774.23view
D AMBRA THOMAS EChairman, Board of Directors 2015-11-09Sell50,000$19.6-32.09view

Press Releases about AMRI :

Quarterly/Annual Reports about AMRI:

News about AMRI:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 

More From Other Websites
ALBANY MOLECULAR RESEARCH INC Financials Mar 23 2017
AMRI Receives CMO Leadership Awards for Excellence Mar 22 2017
ALBANY MOLECULAR RESEARCH INC Files SEC form 10-K, Annual Report Mar 16 2017
AMRI to Present at Barclays Global Healthcare Conference Mar 03 2017
Albany Molecular Research, Inc. :AMRI-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22,... Feb 22 2017
Albany Molecular Research 4Q Net Misses Street Feb 22 2017
Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US :... Feb 22 2017
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 21 2017
Edited Transcript of AMRI earnings conference call or presentation 21-Feb-17 1:30pm GMT Feb 21 2017
Albany Molecular Research posts 4Q loss Feb 21 2017
Albany Molecular Research posts 4Q loss Feb 21 2017
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize... Feb 21 2017
AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook Feb 21 2017
Q4 2016 Albany Molecular Research Inc Earnings Release - Before Market Open Feb 21 2017
[2/15] Today's Top 10 Long/Short Estimize Signal Scores Feb 15 2017
AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call Feb 15 2017
[2/7] Today's Top 10 Long/Short Estimize Signal Scores Feb 07 2017
AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery Feb 07 2017
Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : January 20, 2017 Jan 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)